dopl technologies

Dopl Technologies is a Bothell, Washington-based medical technology company developing a remotely operated robotic ultrasound platform intended to extend diagnostic imaging to rural and workforce-constrained regions. Its product ecosystem comprises Traverse, a remote robotic ultrasound system; Dopl Connect, a secure connectivity and data platform; and SonoFlex, a distributed clinical workforce and workflow management solution. Together these are designed to let credentialed sonographers perform diagnostic ultrasound exams on patients on demand across multiple sites without being physically present. As of the company's 2026 statements, Traverse is under development and not yet commercially available.

While pursuing regulatory clearance, Dopl operates CareBridge, a service that supplies select hospitals with traveling sonographers to provide in-person, end-to-end diagnostic ultrasound coverage. The company states that patients in communities where it operates have seen up to a 90% reduction in wait times, and that participating hospital systems are planned to be the first to transition their imaging services to the telerobotic ecosystem after FDA clearance. Dopl has completed FDA pre-submission engagement, established a 510(k) pathway, and holds patented technology; CEO Ryan James said the company was nearing design freeze in mid-2026 and planned to submit for FDA review in 2027.

The company frames a large addressable need, citing more than 50 million people in the United States affected by an ultrasound access gap and estimating a $40 billion annual reimbursement opportunity for U.S. hospitals as telerobotic imaging scales. It also expects to benefit from the Rural Health Transformation Program, a $50 billion federal effort distributing funds in every state across fiscal years 2026 to 2030 for innovations that expand access to care.

Founding story

Dopl Technologies was founded in 2022 by CEO Ryan James, a former NVIDIA medical AI engineer, together with Chief Operating Officer Steve Seslar, a pediatric cardiologist and electrophysiologist, and Chief Medical Officer Wayne Monsky, an interventional radiologist. The three began researching novel care delivery methods together at the University of Washington in 2017, and the company was formed to address the gap in imaging and healthcare access for rural and workforce-constrained regions.

Business model

Dopl sells into hospitals and health systems, positioning its platform as a cost-efficient, revenue-generating model that lets skilled sonographers work remotely while hospitals retain imaging volume. Ahead of FDA clearance, it generates activity through CareBridge, a traveling sonographer staffing and coverage service delivered to select hospitals, with those sites intended to convert to the telerobotic platform once cleared.

Current revenue-generating activity comes from the CareBridge in-person sonographer coverage service delivered to hospitals; the planned telerobotic offering is framed around hospital imaging reimbursement, with the company estimating a $40 billion annual U.S. hospital reimbursement opportunity as telerobotic imaging scales.

Traction

Reported traction as of mid-2026 includes the CareBridge service running at select hospitals with up to 90% reductions in patient wait times, trust from a number of critical access hospitals across Washington State, a letter of intent with a rural healthcare collaborative of 31 critical access hospitals, completed FDA pre-submission engagement, ongoing clinical evaluations, and a team of 10 employees.

Latest developments

In July 2026 Dopl announced an oversubscribed $6.3 million seed round led by SpringTide Ventures to fund product verification and validation, FDA submission and clearance activities, clinical evaluation, and initial market release, and to hire staff for the regulatory process. The company said it was close to design freeze, planned to submit for FDA review in 2027, and was conducting clinical evaluations. It was also named a finalist for Startup of the Year at the 2026 GeekWire Awards.